Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: A nested case-control study using IgG titer against Hp surface antigen

Acta Oncologica

Volumn 47, Issue 3, 2008, Pages 360-365

  Tatemichi, Masayuki ^a,b   Sasazuki, Shizuka ^a   Inoue, Manami ^a   Tsugane, Shoichiro ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; CARCINOGENESIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INTESTINE CANCER; JAPAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; STOMACH CANCER;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; ATROPHY; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FOLLOW-UP STUDIES; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; JAPAN; MALE; MIDDLE AGED; PEPSINOGEN A; PEPSINOGEN C; PROSPECTIVE STUDIES; STOMACH; STOMACH NEOPLASMS;

EID: 40949108510     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860701843035     Document Type: Article

References (31)

1. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
2. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006;98:1445-52.
3. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53.
4. Vauhkonen M, Vauhkonen H, Sipponen P. Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol 2006;20:651-74.
5. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-79.
6. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: A meta-analysis. Am J Gastroenterol 1999;94:2373-9.
7. Sasazuki S, Inoue M, Iwasaki M, Otani T, Yamamoto S, Ikeda S, et al. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: A nested case-control study. Cancer Epidemiol Biomarkers Prev 2006;15:1341-7.
8. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987;22:133-41.
9. Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004;11:141-7.
10. Marchildon P, Balaban DH, Sue M, Charles C, Doobay R, Passaretti N, et al. Usefulness of serological IgG antibody determinations for confirming eradication of Helicobacter pylori infection. Am J Gastroenterol 1999;94:2105-8.
11. Nishizono A, Gotoh T, Fujioka T, Murakami K, Kubota T, Nasu M, et al. Serological assessment of the early response to eradication therapy using an immunodominant outer membrane protein of Helicobacter pylori. Clin Diagn Lab Immunol 1998;5:856-61.
12. Koizumi W, Tanabe S, Imaizumi H, Hibi K, Kida M, Ohida M, et al. Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection. Hepatogastroenterology 2003;50:293-6.
13. Zagari RM, Pozzato P, Martuzzi C, Fuccio L, Martinelli G, Roda E, et al. 13C-urea breath test to assess Helicobacter pylori bacterial load. Helicobacter 2005;10:615-9.
14. WHO International classification of diseases for oncology. 2nd ed. Geneva: WHO; 1990.
15. Japanese Research Society for Gastric Cancer. The general rules for gastric cancer study. 12th ed. Tokyo: Kanehara; 1993.
16. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. APMIS 1965;64:31-49.
17. Karnes WE, Jr, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-74.
18. Tatemichi M, Kabuto M, Tsugane S. Effect of smoking on serum pepsinogen I level depends on serological status of Helicobacter pylori. Jpn J Cancer Res 2001;92:243-8.
19. Fujishiro M, Oka M, Yahagi N, Nakamura M, Kakushima N, Kodashima S, et al. Correlation of serum pepsinogens and gross appearances combined with histology in early gastric cancer. J Exp Clin Cancer Res 2006;25:207-12.
20. Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004;53:1082-9.
21. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
22. Togawa S, Joh T, Itoh M, Katsuda N, Ito H, Matsuo K, et al. Interleukin-2 gene polymorphisms associated with increased risk of gastric atrophy from Helicobacter pylori infection. Helicobacter 2005;10:172-8.
23. Taguchi A, Ohmiya N, Shirai K, Mabuchi N, Itoh A, Hirooka Y, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 2005;14:2487-93.
24. Li C, Xia B, Yang Y, Li J, Xia HH. TNF gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in Chinese population. Am J Gastroenterol 2005;100:290-4.
25. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003;125:364-71.
26. Macarthur M, Hold GL, El-Omar EM. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 2004;286:G515-20.
27. van den Engel NK, Winter H, Ruttinger D, Shau I, Schiller M, Mayer B, et al. Characterization of immune responses in gastric cancer patients: A possible impact of H. pylori to polarize a tumor-specific type 1 response? Clin Immunol 2006;120:285-96.
28. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003;125:1636-44.
29. Tatemichi M, Hamada GS, Nishimoto IN, Kowalski LP, Iriya K, Rodrigues JJ, et al. Ethnic difference in serology of Helicobacter pylori CagA between Japanese and non-Japanese Brazilians for non-cardia gastric cancer. Cancer Sci 2003;94:64-9.
30. Fujioka T, Tokieda M. Validity of serum anti-Helicobacter pylori antibody using enzyme immunoassay for the diagnosis in eradication of Helicobacter pylori. Jpn J Med Pharm Sci 2000;43:573-9.
31. Iwasaki M, Otani T, Yamamoto S, Inoue M, Hanaoka T, Sobue T, et al. Background characteristics of basic health examination participants: The JPHC Study Baseline Survey. J Epidemiol 2003;13:216-25.